| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -7.2e-05 | 1 |